Infertility and Gynecologic Disorders in South Asian Women
Infertility, Gynecologic Disorders, and Chronic Disease: Pathways to Improved Care for South Asian Women
Shreya Bhatia1, Nithasa Nagaraj2, Amita Vyas3,
- Medical Student, Vanderbilt University School of Medicine
- Assistant Professor, George Washington University
- Professor, George Washington University
OPEN ACCESS
PUBLISHED: 31 December 2024
CITATION: Bhatia, S., Nagaraj, N., & Vyas, A. (2024). Infertility, Gynecologic Disorders, and Chronic Disease: Pathways to Improved Care for South Asian Women. Medical Research Archives, 12(1). https://doi.org/10.18103/mra.v12i1.24087
COPYRIGHT: © 2025 European Society of Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
DOI: https://doi.org/10.18103/mra.v12i12.6115
ISSN 2375-1924
Abstract
This study explores the intersection of gynecologic disorders, infertility, and chronic diseases among South Asian American women, an under-researched population. Using data from 2,677 participants in a web-based survey, we examined the prevalence of infertility, gynecologic conditions (uterine fibroids, endometriosis, and polycystic ovary syndrome [PCOS]), and their associations with chronic health outcomes, including type 2 diabetes (T2DM), obesity, hypertension, and gestational diabetes (GDM). Multivariate logistic regression models adjusted for age, education, and employment status were used to assess these relationships.
Keywords
- Infertility
- Gynecologic Disorders
- Chronic Disease
- South Asian Women
- Healthcare Disparities
Introduction
Infertility, defined as the inability to conceive after trying for 12 months, affects 15% of women of reproductive age in the U.S.¹ Infertility diagnosis goes beyond the pursuit of family building but one that is often tied to broader health challenges, particularly stemming from underlying gynecologic diagnosis. Conditions like polycystic ovary syndrome, endometriosis, and uterine fibroids are among the most common contributors to infertility in women of reproductive age¹. These conditions disrupt normal ovulatory cycles, impact hormonal balances, and can result in physical damage to the reproductive organs, making conception difficult or impossible without medical intervention². For instance, polycystic ovary syndrome, a hormonal disorder characterized by irregular periods and ovarian cysts, affects up to 4-7% of women and is the leading cause of anovulation, where the ovary fails to release an egg³. Women with polycystic ovarian syndrome have rates of infertility up to 70-80%³. Endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, can lead to scarring, adhesions, and blocked fallopian tubes, severely hindering a woman’s ability to conceive³. Endometriosis affects anywhere from 10-15% of all women of reproductive age⁴⁵. Furthermore, the frequency of occurrence of infertility in patients with endometriosis is as high as 30-50%³¹. Finally, uterine fibroids are the most common type of tumor found in women and are frequently observed in patients experiencing infertility⁶. Fibroids are estimated to be the primary cause of infertility in approximately 2-3% of women, underscoring their impact on reproductive health⁶.
The impact of infertility has increased risks of preterm delivery, low birth weight, and perinatal mortality⁷, in addition to severe maternal morbidity, chronic disease, and other adverse health outcomes⁸⁻¹¹. Furthermore, gynecologic conditions such as endometriosis and polycystic ovary syndrome have been found to be linked to elevated risk of chronic diseases due to mechanisms like hormonal disruptions, chronic inflammation, insulin resistance, obesity, mental health impacts and epigenetic changes¹³⁸¹³. Women with polycystic ovary syndrome, for example, are at an increased risk of developing insulin resistance, type 2 diabetes, cardiovascular disease, and metabolic syndrome due to hormonal imbalances that often accompany the condition¹³. Endometriosis, too, is associated with chronic pain and increased risk of ovarian cancer and may lead to long-term inflammatory responses³. Further, in a study conducted by Haan et al., women with fibroids were found to have remarkably high hypertension risk compared to their controls¹². Finally, mental health challenges like depression also interact with physical health risks, and epigenetic changes may predispose individuals to chronic illnesses¹²⁻¹³. These interconnected factors highlight the long-term health risks for individuals with gynecologic conditions and infertility¹²⁻¹³.
SOUTH ASIANS: INFERTILITY AND CHRONIC HEALTH ISSUES
As the U.S. becomes increasingly diverse, it is important to understand how infertility impacts different populations, especially minority groups like South Asian women. South Asian women in the U.S., a growing demographic, face unique reproductive health challenges. Although research on this group is limited, existing evidence suggests that they may be at higher risk for certain gynecologic conditions that contribute to infertility, such as polycystic ovary syndrome, endometriosis, and uterine fibroids. Cultural factors, stigma around infertility, and limited access to reproductive health services further complicate their ability to seek and receive appropriate care. Moreover, traditional gender roles and expectations can place additional pressure on South Asian women to conceive, making infertility an even more complex and sensitive issue within these communities¹⁵.
The U.S. is home to approximately 5.4 million South Asians¹⁶. The South Asian American population, comprising individuals with origins in Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka, exhibits higher risks of gynecologic disorders, such as endometriosis, uterine fibroids, and polycystic ovary syndrome, which often contribute to infertility¹⁷⁻¹⁸. Data specifically addressing the prevalence of these conditions among South Asian women living in the U.S. is limited. However, some studies illustrate the significance of this issue in the U.S. and globally. In a study conducted by Velarde, Buca, and Habana in 2023, authors noted that Filipinos, Indians, Japanese, and Koreans are among the top Asian ethnicities who are more likely to have endometriosis than Caucasian women¹⁸⁻¹⁹. Further, Shan et al., in a study conducted in 2016 in the U.S., noted a difference in the prevalence of polycystic ovary syndrome between South Asian and Caucasian women, finding that 20.5% of South Asian women had polycystic ovarian syndrome compared to 11.8% of Caucasian women²⁰. South Asian women in the UK exhibit particularly high rates of polycystic ovary syndrome, with a prevalence of 52% compared to 22% in Caucasian women²¹.
In addition to an increased risk for gynecologic conditions, South Asians are at a higher risk of developing type 2 diabetes mellitus and cardiovascular disease compared to other racial and ethnic groups⁸⁻¹¹. This elevated risk is mainly due to metabolic factors, including abdominal obesity and a higher concentration of visceral fat, intramuscular fat, and intrahepatic fat²². In 2016, the prevalence of diabetes among South Asians was reported at 23%, significantly higher than East Asians (14%) and non-Hispanic (12%)²⁰. Additionally, South Asian American women face a fourfold increased risk of gestational diabetes compared to other ethnicities²⁵. This community also suffers from disproportionately high cardiometabolic risks and mortality from atherosclerotic cardiovascular disease relative to non-Hispanic White adults and other Asian subgroups²⁷. Specifically, the Mediators of Atherosclerosis in South Asians Living in America study (also referred to as the MASALA study) found that hypertension affects 43% of South Asian American men and 35% of women aged 40-85²²⁵. In comparison, the prevalence of hypertension across the general U.S. population is 49.6%²⁴.
The long-term health challenges posed by these gynecological conditions are often compounded by infertility, adding significant emotional and physical burdens on women. Infertility not only impacts reproductive health but also contributes to a broader spectrum of psychological distress and chronic health issues. It is crucial for healthcare systems to recognize the interrelated nature of infertility, gynecological conditions, and chronic disease in order to design effective medical and public health interventions for women’s well-being.
This study aims to explore the intersection of infertility, gynecologic disorders and chronic health outcomes, specifically focusing on South Asian women living in the U.S. By addressing this underexplored area, the research seeks to fill a critical gap in the literature by providing a descriptive landscape of infertility and gynecologic conditions in this population, and its relationship to chronic disease, and inform targeted interventions to reduce the burden of diabetes and infertility within this group.
Methods
STUDY DESIGN AND PARTICIPANTS
This study utilized a purposeful sample of 2677 of self-identified South Asian American women living in the U.S. Data were collected through a self-administered, anonymous web-based survey developed using the Qualtrics platform. Convenience sampling was used to recruit a diverse participant pool, with a survey link distributed electronically via South Asian American national listservs, organizations, and social media platforms. Once the initial convenience sample was established, participants were encouraged to forward the survey to eligible friends, colleagues, and social networks. The survey took approximately 15-20 minutes, and participants could anonymously enter a drawing for a $50 Amazon gift card upon completion. All procedures for this study, including the protection of human subjects, were reviewed and approved by the GW Institutional Review Board (IRB) at the GW Office of Human Research (IRB #: NCR234807).
You said:
Table 2. Health Factors in South Asian American Women
| Health Factors in South Asian American Women | Total Sample Population N = 2634 n (%) |
|---|---|
| Have you ever had trouble becoming pregnant after attempting for 12 months or longer? | 984 (36.9) |
| Have you ever been diagnosed with any of the following? | |
| Uterine Fibroids | 414 (15.5) |
| Endometriosis | 352 (13.2) |
| Polycystic Ovarian Syndrome | 461 (17.3) |
| Cardiovascular Disease | 420 (16.4) |
| Obesity | 759 (29.5) |
| Hypertension | 541 (21.0) |
| Type 2 Diabetes | 315 (12.4) |
| Pregnancy | 1910 (73.2) |
| Gestational Diabetes* | 481 (25.9) |
*This question was only asked to those participants who answered ‘yes’ to pregnancy.
Table 3 presents odds ratios from four logistic regression models for (1) Type 2 diabetes, (2) Obesity, (3) High blood pressure, and (4) Gestational diabetes. The analysis shows that uterine fibroids were significantly associated with all four outcomes, with the highest odds observed for type 2 diabetes (OR: 3.019; 95% CI 2.128–4.823) and high blood pressure (OR: 2.786; 95% CI: 2.134–3.639). Similarly, endometriosis was strongly linked to type 2 diabetes (OR: 2.626; 95% CI: 1.818–3.795), gestational diabetes (OR: 2.152; 95% CI: 1.586–2.916), and other outcomes. Women with polycystic ovarian syndrome had the highest odds of developing type 2 diabetes (OR: 3.168, 95% CI: 2.231–4.499), with significant associations also seen for obesity, high blood pressure, and gestational diabetes. Additionally, women who experienced difficulty conceiving after 12 months or longer were at significantly increased risk for all four conditions, with notably increased odds with high blood pressure (OR: 2.315, 95% CI: 1.843–2.909) and obesity (OR: 1.925, 95% CI: 1.581–2.343). These models were adjusted for age, education, employment, and income, and all associations were statistically significant at p < 0.001.
Table 3. Multivariate Logistic Analysis for various forms of Gynecologic Disorders and Infertility
| Type 2 Diabetes OR (CI) – model 1 | Obesity OR (CI) – model 2 | High Blood Pressure OR (CI) – model 3 | Gestational Diabetes OR (CI) – model 4 | |
|---|---|---|---|---|
| Uterine Fibroids | 3.019 (2.128–4.283)*** | 1.629 (1.264–2.100)*** | 2.786 (2.134–3.639)*** | 1.665 (1.244–2.229)*** |
| Endometriosis | 2.626 (1.818–3.795)*** | 1.515 (1.154–1.987)** | 1.884 (1.409–2.519)*** | 2.152 (1.586–2.916)*** |
| Polycystic ovary syndrome | 3.168 (2.231–4.499)*** | 1.704 (1.342–2.165)*** | 2.297 (1.773–2.997)*** | 2.141 (1.606–2.853)*** |
| Trouble becoming pregnant after 12 months or longer? | 2.076 (1.430–3.014)*** | 1.925 (1.581–2.343)*** | 2.315 (1.843–2.909)*** | 2.054 (1.599–2.638)*** |
Adjusted for age, education, employment, and income
Statistical Significance: *p<0.05, **p<0.01, ***p<0.001
Discussion
The results of this study provide significant insight into the health challenges faced by South Asian women living in the U.S., particularly concerning reproductive health and chronic disease prevalence. Notably, nearly one-third of participants (36.9%) reported difficulties conceiving after attempting for 12 months or longer. This statistic signals a need for increased attention to fertility issues within this population. This aligns with existing research indicating that South Asian women have a higher prevalence of gynecologic conditions, including polycystic ovary syndrome, endometriosis, and uterine fibroids, all of which are strongly associated with infertility. This study also highlights the higher rates of these conditions among South Asian women living in the U.S., with polycystic ovary syndrome affecting 17.3%, endometriosis 13.2%, and fibroids 15.5% of participants, reinforcing the existing literature on the elevated reproductive health risks within this population.
The association between gynecologic disorders and metabolic conditions, such as type 2 diabetes, obesity, and hypertension, is particularly compelling. The logistic regression models demonstrate a significant correlation between gynecologic conditions and chronic conditions, as seen in Table 3. These findings emphasize the interplay between reproductive health and broader metabolic risk factors, particularly in South Asian women living in the U.S. This study supports previous research suggesting that reproductive disorders like polycystic ovary syndrome, which is also linked to metabolic syndrome, may play a key role in the development of chronic diseases. Women with polycystic ovary syndrome exhibited the highest odds of developing type 2 diabetes (OR 3.168), underscoring the need for early screening and intervention to manage metabolic complications in this population.
Endometriosis was another condition significantly associated with both gestational diabetes and type 2 diabetes. Women diagnosed with endometriosis were more than twice (OR 2.626) as likely to develop type 2 diabetes and 2.152 times more likely to develop gestational diabetes. Those associations suggest that the inflammatory processes and hormonal imbalances characteristic of endometriosis may contribute to long-term metabolic dysregulation. Additionally, the prevalence of gestational diabetes among women who had been pregnant was notably high (25.9%), particularly given the increased odds of gestational diabetes in women with gynecologic disorders. These findings reflect the broader cardiometabolic risks that South Asian women face during and after pregnancy, further emphasizing the need for targeted healthcare interventions in this population.
This study also draws attention to the role of infertility and its relationship with chronic diseases. Women who have experienced infertility (defined as difficulty conceiving for 12 months or longer) had a 1.925 increased odds of developing obesity; 2.315 increased odds of developing hypertension; and 2.076 odds of developing type 2 diabetes, highlighting the long-term implications of fertility issues. These results suggest that infertility may serve as an early indicator of cardiometabolic risk, particularly in populations with known vulnerabilities, such as South Asian American women. These findings suggest that addressing reproductive health early in life may help mitigate the risk of developing chronic diseases later on, supporting a life-course perspective on health.
These results carry significant clinical and public health implications. First, integrated care models that address both reproductive and metabolic health are crucial for improving outcomes for South Asian women. For instance, women diagnosed with polycystic ovary syndrome should receive counseling on diet, physical activity, and weight management, thereby reducing the risk of developing diabetes and cardiovascular diseases. Furthermore, healthcare providers must be trained on cultural sensitivity and awareness to effectively address the unique challenges and needs of South Asian women. Public health interventions should focus on South Asian women, disaggregated from all Asian American women or all women. Culturally tailored interventions promoting lifestyle interventions that include diet and exercise tailored to reduce the risk of metabolic syndrome, especially in women with polycystic ovarian syndrome or other hormone-related disorders. Social support networks for South Asian women dealing with infertility and other gynecologic conditions provide psychosocial support and reduce the stigma associated with these conditions.
Finally, there is a need for longitudinal research to track the health outcomes of South Asian women with gynecologic disorders over time to understand better causal relationships and the long-term impact of these conditions on metabolic health. These studies should also focus on the biological mechanisms that link gynecologic disorders to chronic diseases in South Asian women. This could include studies on inflammatory markers, hormonal profiles, and genetic predispositions.
Despite the strengths of this study, including a large sample size and a focus on an understudied population, several limitations should be acknowledged. First, the study is a cross-sectional design, which limits our ability to draw causal inferences between gynecologic conditions and the development of chronic health conditions such as diabetes, cardiovascular disease, and obesity. Longitudinal studies are needed to confirm these associations and to explore the potential mechanisms linking gynecologic conditions to chronic health. Additionally, the reliance on self-reported gynecologic conditions can lead to inaccuracies, as participants might misunderstand medical terminology, underreport symptoms, or choose not to disclose specific health issues due to social stigma or privacy concerns. Future studies should aim to use more objective measures of gynecologic conditions, such as medical records, to minimize this bias.
Conclusion
In conclusion, this study provides critical evidence on the intersection between infertility, gynecologic disorders, and chronic diseases in South Asian women living in the U.S., emphasizing the compounded health burdens these women face. By highlighting the associations between reproductive health conditions—such as polycystic ovary syndrome, uterine fibroids, and endometriosis—and chronic diseases like type 2 diabetes, hypertension, and obesity, this research underscores the need for healthcare systems to adopt a culturally sensitive integrated approach to care. The findings highlight infertility as both a significant health issue and a potential early marker for cardiometabolic risk in this population. Future research should further investigate the biological mechanisms underlying these associations and explore culturally tailored interventions aimed at improving reproductive and metabolic health outcomes for South Asian women living in the U.S. Addressing these interrelated health conditions holistically will be essential in reducing the long-term burden of chronic diseases and improving the overall health outcomes in this growing and high-risk population.
Conflict of Interest:
None
Funding Statement:
This publication was made possible by the George Washington University Center of Excellence in Maternal and Child Health under Grant Number T76MC35370 from the Health Resources and Services Administration (HRSA) Maternal and Child Health Bureau. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Health Resources & Services Administration (HRSA) Maternal and Child Health Bureau.
Acknowledgements:
The authors acknowledge the assistance and support of the following individuals: Shikha Chandarana, Belicia Badibanga, Hannah Dease, Corina Galindo, Bailey Newton, Addison Montgomery, and Maria Wallace in completion of this study. Funding was provided by the GW Center for Excellence in Maternal and Child Health.
Statement and Declarations:
The following manuscript has not been published elsewhere and is not under review for submission elsewhere. This study was funded by The George Washington University Center of Excellence in Maternal and Child Health under Grant No T76MC35370 from the Health Resources & Services Administration (HRSA) Maternal and Child Health Bureau. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Health Resources & Services Administration (HRSA) Maternal and Child Health Bureau. There is no conflict of interest or disclosing of any competing interests that may exist. This study was approved by the Institutional Review Board at the George Washington University Office of Human Research (IRB Number: NCR234807).
Informed Consent Requirement:
Informed consent was obtained from all participants involved in this research.
ORCID ID:
Shreya Bhatia: 0000-0002-3661-7438
Nitasha Nagaraj: 0000-0002-6417-6692
Amita Vyas: 0000-0003-2358-5569
References
1. Murugappan G, Leonard SA, Farland LV, et al. Association of infertility with atherosclerosis cardiovascular disease among post-menopausal participants in the Women’s Health Initiative. Fertil Steril. 2022;117(5):1038-1046. doi:10.1016/j.fertns tert.2022.02.005.
2. Singh S, Pal N, Shubham S, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454. Published 2023 Feb 11. doi: 10.3390/jcm12041454.
3. Vannucci S, Clifton VL, Fraser IS, et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2016;22(1):104-115. doi:10.1093/humupd/dmv044
4. Parasar P, Ozcan P, Terry KL. Endometriosis: epidemiology, diagnosis and clinical Management. Curr Obstet Gynecol Rep. 2017;6(1):34-41. doi: 10.1007/s13669-017-0187-1.
5. Guidice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789-1799. doi: 10.1016/S0140-6736(04)17403-5.
6. Freytag D, Günther V, Maass Nicolai, Alkatout I. Uterine fibroids and infertility. Diagnostics (Basel). 2021;11(8): 1455. Published 2021 Aug 12. doi: 10.3390/diagnostics1108145.
7. Hanson B, Johnstone E, Dorais J, Silver B, Peterson CM, Hotaling J. Female infertility, infertility-associated diagnoses, and comorbidities: a review. 2017; 34(2):167-177. doi:10.1007/s10815 -016-0836-8.
8. Murugappan G, Li S, Alvero RJ, Luke B, Eisenberg ML. Association between infertility and all-cause mortality: analysis of US claims data. Am J Obstet Gynecol. 2021;225:57.e1–11.7.
9. Murugappan G, Li S, Lathi RB, Baker VL, Eisenberg ML. Increased risk of incident chronic medical conditions in infertile women: analysis of US claims data. Am J Obstet Gynecol. 2019;220(5): 473.e1–473.e14. doi:10.1016/j.ajog.2019.01.214
10. Murugappan G, Li S, Lathi RB, Baker VL, Luke B, Eisenberg ML. Increased risk of severe maternal morbidity among infertile women: analysis of US claims data. Am J Obstet Gynecol. 2020;223(3):40 4.e1–404.e20. doi:10.1016/j.ajog.2020.02.027
11. Murugappan G, Li S, Lathi RB, Baker VL, Eisenberg ML. Risk of cancer in fertile women: analysis of US claims data. Hum Reprod. 2019;34(5) :894–902. doi:10.1093/humrep/dez018
12. Yu X, Xu J, Song B, et al. The role of epigenetics in women’s reproductive health: the impact of environmental factors. Front Endocrinol (Lausanne). 2024;15:1399757. Published 2024 Sep 13. doi: 10.3389/fendo.2024.1399757.
13. Hartnett Y, Conlon-Trant, R, Duffy R, Doherty AM. Cross-disciplinary working between gynaecologists and mental healthcare professionals: a mixed-methods systematic review protocol. BMJ Open. 2024;14(10):e091378. Published 2024 Oct 16. doi: 10.1136/bmjopen-2024-091378.
14. Haan YC, Diemer FS, Van Der Woude L, Van Montfrans GA, Oehlers GP, Brewster LM. The risk of hypertension and cardiovascular disease in women with uterine fibroids. J Clin Hypertens (Greenwich). 2018;20(4):718-726. doi:10.1111/jch.13253
15. Mumtaz Z, Shahid U, Levay A. Understanding the impact of gendered roles on the experiences of infertility amongst men and women in Punjab. Reprod Health. 2013;10:3. Published 2013 Jan 15. doi: 10.1186/1742-4755-10-3.
16. Demographic snapshot of South Asians in the United States [Internet]. South Asian Americans Leading Together (SAALT); 2019. Available from: https://saalt.org/wp-content/uploads/2019/04/SAALT-Demographic-Snapshot-2019.pdf.
17. Guo L, Gordon NP, Chandra M, Dayo O, Lo JC. The risks of polycystic ovary syndrome and diabetes vary by ethnic subgroup among young Asian women. Diabetes Care. 2021; 44(6):e129-e130. doi: 10.2337/dc21-0373.
18. Velarde MC, Bucu MEM, Habana MAE. Endometriosis as a highly relevant yet neglected gynecologic condition in Asian women. Endocr Connect. 2023;12(11):e230169. Published 2023 Oct 5. doi: 10.1530/EC-23-0169.
19. Yamamoto A, Johnstone EB, Bloom MS, Huddleston HG, Fujimoto VY. A higher prevalence of endometriosis among Asian women does not contribute to poorer IVF outcomes. J Assist Reprod Genet. 2017;34(6):765-774. doi:10.1007/s10815-017-0919-1
20. Tomassetti C, D’Hooghe T. Endometriosis and infertility: insights into the causal link and management strategies. Best Pract Res Clin Obstet Gynaecol. 2018;51:25-33. doi:10.1016/j.bpobgyn.2018.06.002.
21. Shah MS, Caballes M, Lathi RB, Baker VL, Westphal LM, Milki AA. In vitro fertilization outcomes after fresh and frozen blastocyst transfer in South Asian compared with Caucasian women. Fertil Steril. 2016;105(6): 1484-1487. doi:10.1016/j.fertnstert. 2016.02.027
22. Pillay O, Khan K, Ojha K., Polycystic Ovary Syndrome in South Asians. Polycystic Ovary Syndrome, 2024: 185-190.
23. Deshpande A, Shah NS, Kandula NR. Obesity and cardiovascular risk among South Asian Americans. Curr Cardiovasc Risk Rep. 2023;17(3) :73-82. doi: 10.1007/s12170-023-00714-5.
24. Kandula NR, Kanaya AM, Liu K, et al. Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study. J Am Heart Assoc. 2014;3(5): e001117. doi: 10.1161/JAHA.114.001117.
25. Gujral UP, Kanaya AM. Epidemiology of diabetes among South Asians in the United States: lessons from the MASALA study. Ann N Y Acad Sci. 2021;1495(1):24-39. doi: 10.1111/nyas.14530.
26. Chobufo MD, Gayam V, Soluny J, et al. Prevalence and control rates of hypertension in the USA: 2017-2018. Int J Cardiol Hypertens. Published 2020 Jul 31. doi: 10.1016/j.ijchy.2020.100044
27. Centers for Disease Control and Prevention. National health and nutrition examination survey: 2015-2016 data documentation, codebook, and frequencies.https://wwwn.cdc.gov/Nchs/Nhanes/limited_access/RHQ_I_R.htm.
28. Robertson HA, Chaudhary Nagaraj N, Vyas AN. Family violence and child sexual abuse among south asians in the US. J Immigrant Minority Health. 2015;18(4):921. doi: 10.1007/s10903-015-0227-8.
29. Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycemic control. Health Qual Life Outcomes. 2013; 11:138. Published 2013 Aug 13. doi:10.1186/1477-7525-11-138 .
30. Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111(3):564–572. doi: 10.1542/peds.111.3.564
31. Bulletti C, Coccia ME, Battistoni S, Borini A. Endometriosis and infertility. J Assist Reprod Genet. 2010;27(8):441-447. doi:10.1007/s10815-010-9436-1
32. Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovarian syndrome: approach to clinical practice. Clinics (Sao Paulo). 2015;70(11):765-769. doi:10.6061/clin ics/2015(11)09
Most read articles by the same author(s)
- Anisa Amiji, Nitasha Nagaraj, DrPH, Amita Vyas, PhD, Exploring the Relationship Between Birth Weight and Diabetes Among South Asian-American Women , Medical Research Archives: Vol 12 No 11 (2024): November Issue, Issue 11, VOl.12